(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
3 days till quarter result
(bmo 2024-05-07)
Expected move: +/- 12.80%
@ $10.44
Utstedt: 13 feb 2024 @ 16:07
Avkastning: 56.66%
Forrige signal: feb 12 - 19:04
Forrige signal:
Avkastning: -6.09 %
Live Chart Being Loaded With Signals
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States...
Stats | |
---|---|
Dagens volum | 10 535.00 |
Gjennomsnittsvolum | 29 570.00 |
Markedsverdi | 96.43M |
EPS | $0 ( 2024-05-02 ) |
Neste inntjeningsdato | ( $-1.940 ) 2024-05-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.830 |
ATR14 | $0.145 (0.88%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-05-01 | Zung Jonathan B. | Buy | 500 000 | Employee stock option (right to buy) |
2023-05-01 | Zung Jonathan B. | Buy | 0 | |
2023-01-23 | Kaitin Kenneth I | Buy | 85 000 | Non Qualified Stock Option |
2023-01-23 | Hohneker John | Buy | 85 000 | Non Qualified Stock Option |
2023-01-23 | Rubin Marc | Buy | 85 000 | Non Qualified Stock Option |
INSIDER POWER |
---|
86.47 |
Last 97 transactions |
Buy: 14 857 117 | Sell: 1 304 959 |
Curis Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
BUR | 0.887 |
ARCT | 0.884 |
PSTV | 0.882 |
IFRX | 0.882 |
FTRI | 0.881 |
EZFL | 0.878 |
CWBC | 0.876 |
VTSI | 0.866 |
SBET | 0.864 |
MDRR | 0.861 |
10 Mest negative korrelasjoner | |
---|---|
AMRB | -0.912 |
PKOH | -0.886 |
SMH | -0.881 |
SNCY | -0.873 |
AMRS | -0.856 |
CHB | -0.852 |
GPRE | -0.85 |
VOXX | -0.846 |
FLDM | -0.844 |
VTRU | -0.833 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Curis Inc Økonomi
Annual | 2023 |
Omsetning: | $10.02M |
Bruttogevinst: | $9.81M (97.88 %) |
EPS: | $-8.96 |
FY | 2023 |
Omsetning: | $10.02M |
Bruttogevinst: | $9.81M (97.88 %) |
EPS: | $-8.96 |
FY | 2022 |
Omsetning: | $10.16M |
Bruttogevinst: | $9.91M (97.47 %) |
EPS: | $-12.92 |
FY | 2021 |
Omsetning: | $10.65M |
Bruttogevinst: | $10.12M (94.99 %) |
EPS: | $-0.500 |
Financial Reports:
No articles found.
Curis Inc
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma; CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas; and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.